One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent

Objectives. To evaluate clinical events in a specifically selected cohort of patients with obstructive coronary artery disease (CAD), using a new generation thin-strut bare cobalt-chromium coronary stent. Methods. Patients with single- or multi-vessel, stable or unstable CAD eligible for percutaneous implantation of at least one bare cobalt-chromium stent were evaluated in a single-centre registry. Prospective pre-specified criteria for bare cobalt-chromium stent implantation in our centre were: any acute ST-elevation myocardial infarction (MI), otherwise 1) de novo coronary lesion, and 2) lesion length <20 mm, and 3) reference vessel diameter >2.6 mm, and 4) no diabetes, unless reference vessel diameter >3.5 mm. Endpoints, retrospectively collected, were death, MI and clinically driven target-lesion revascularisation (TLR) and target-vessel revascularisation (TVR) after 12 months. Results. Between September 2005 and June 2007, 712 patients (48.7% one-vessel, 29.9% two-vessel, 20% three-vessel and 1.4% left main disease; 7.9% diabetics) were treated with 800 bare cobalt-chromium stents, for stable angina (40.9%), unstable angina (20.9%) or acute ST-elevation MI (38.2%). The procedural success rate was 99.3%. Peri-procedural MI rate was 2.2% in the semi-elective group. At 12 months there were 17 deaths (2.4%), of which nine non-cardiac, 20 (2.8%) MI, 19 (2.7%) TLR and 29 (4.1%) TVR. Early and late definite stent thrombosis occurred in four (0.6%) and three (0.4%) patients, respectively. Conclusion. A strategy aimed at minimising drug-eluting stent use and combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent is safe and effective at one-year clinical follow-up. (Neth Heart J 2010;18:486-92.)     

Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents

BackgroundAlthough the introduction of drugeluting stents (DES) has been associated with an impressive reduction in target vessel revascularisation, there has been concern about the safety profile. The aim of this study was to determine the incidence of stent thrombosis in real-world patients and evaluate the contribution of drug-eluting stents. Methods A prospective observational cohort study was conducted at a high-volume centre in Utrecht, the Netherlands. All patients who underwent a percutaneous coronary intervention (PCI) between 1 January and 31 December 2005 were evaluated. The patients were pretreated with aspirin and clopidogrel, which was continued for six months in bare metal stents (BMS) and 12 months in DES. ResultsIn 2005, 1309 patients underwent a percutaneous coronary intervention procedure with stent implantation. After a median follow-up of nine months, 1.8% (n=23) of the patients had suffered from stent thrombosis. Two cases could be attributed to incorrect use of antiplatelet agents. In 8/23 cases, a technical reason was found such as an unrecognised dissection or stent underexpansion. The timing of stent thrombosis was acute in 1/23 patients, subacute in 20/23 patients and late in 2/23 patients. In both cases of late stent thrombosis, a BMS had been used. There were no differences in stent thrombosis rates between DES and BMS (1.4 vs. 1.9%, ns.). This is remarkable since DES were used in more complex and longer lesions. ConclusionThe use of DES in routine daily practice does not appear to be associated with a higher rate of stent thrombosis than BMS. (Neth Heart J 2007;15:382-6).     

Role of direct reactivity with metals in chemoprotection by N-acetylcysteine against chromium(VI), cadmium(II), and cobalt(II)

The antioxidant N-acetylcysteine (NAC) is widely used for the assessment of the role of reactive oxygen species (ROS) in various biological processes and adverse drug reactions. NAC has been found to effectively inhibit the toxicity of carcinogenic metals, which was attributed to its potent ROS-suppressive properties. However, the absence of redox activity among some metals and findings from genetic models suggested a more diverse, smaller role of oxidative stress in metal toxicity. Here, we examined mechanisms of chemoprotection by NAC against Cd(II), Co(II), and Cr(VI) in human cells. We found that NAC displayed a broad-spectrum chemoprotective activity against all three metals, including suppression of cytotoxicity, apoptosis, p53 activation, and HSP72 and HIF-1α upregulation. Cytoprotection by NAC was independent of cellular glutathione. NAC strongly inhibited the uptake of all three metals in histologically different types of human cells, explaining its high chemoprotective potential. A loss of Cr(VI) accumulation by cells was caused by NAC-mediated extracellular reduction of chromate to membrane-impermeative Cr(III). Suppression of Co(II) uptake resulted from a rapid formation of Co(II)–NAC conjugates that were unable to enter cells. Our results demonstrate that NAC acts through more than one mechanism in preventing metal toxicity and its chemoprotective activity can be completely ROS-independent. Good clinical safety and effectiveness in Co(II) sequestration suggest that NAC could be useful in the prevention of tissue accumulation and toxic effects of Co ions released by cobalt–chromium hip prostheses.     

Synthetic routes to mixed-ligand cobalt(III) dithiocarbamato complexes containing imidazole, amine and pyridine donors and the X-ray crystal structure of a cobalt(III) bis(dithiocarbamato) histamine complex

The binuclear cobalt complex [Co(2)(Me(2)dtc)(5)](+) reacts with a range of nitrogen donor ligands L' or L' to form an equimolar mixture of Co(Me(2)dtc)(3) and the mixed-ligand complexes [Co(Me(2)dtc)(2)(L')(2)](+) or [Co(Me(2)dtc)(2)(L')](+), where (L')(2) is two monodentate ligands and (L') is one bidentate ligand. The complexes prepared by this route contain the monodentate ligands L'=1-methyl-imidazole, 1-methyl-5-nitro-imidazole and benzimidazole, all of which coordinate to cobalt through an imidazole nitrogen atom. Symmetrical bidentate ligand complexes contain the bisimidazole L'=2,2'-bis(4,5-dimethylimidazole), the diamine L'=1,2-diaminobenzene and the pyridine donors L'=2,2'-bipyridine, 4,4'-dimethyl-2,2'-bipyridine and 1,10-phenanthroline. Two examples of complexes with unsymmetrical bidentate imidazole-amine donors were prepared in which L'=4-(2-aminoethyl)imidazole (histamine) and 2-aminomethylbenzimidazole. All new complexes were fully characterised, and the X-ray crystal structure of the histamine complex [Co(Me(2)dtc)(2)(hist)]ClO(4) is also reported.     

Safety of an oxygen-coordinated niacin-bound chromium(III) complex (NBC): II. Developmental toxicity study in rats

The objective of the present study was to evaluate the teratogenic potential of a novel oxygen-coordinated niacin-bound chromium complex (NBC) in Sprague-Dawley rats. Due to its potential to affect fat synthesis and reduce food intake, processes which are often crucial in normal fetal development, this teratology study was undertaken as part of a multi-generation reproductive investigation. The animals in this study were selected randomly after weaning from each F_2b litter of the F1 generation from the two-generation reproductive toxicity study. To start the teratology study, Sprague-Dawley rat pups (∼30/sex/group) from the F_2b generation were allowed to grow up to 10-12 weeks of age before mating. The rats in treatment group were exposed directly to NBC through feed. The dietary exposure levels were the same as those employed for the two-generation reproductive toxicity study, viz. 4, 15, or 60 ppm. Following mating at maturity, the pregnant rats were observed daily for clinical signs of adverse effects, and body weight and feed consumption were recorded. On the day 20th of the gestation, animals were subjected to a necropsy and caesarean section to examine the uterus, ovaries and fetuses for assessment of different parameters of pregnancy and embryo-fetal defects. In this study, no indications of maternal toxicity, adverse effects on the parameters evaluated for the gravid uteri, external abnormalities in the fetuses, soft tissue abnormalities in the fetuses, or skeletal abnormalities in the fetuses were noted. Based on the results of this developmental toxicity study, NBC was found to benon-teratogenic in Sprague-Dawley rat, at the dietary exposure levels of 4, 15, and 60 ppm, equivalent to the dose levels of 0.50, 2.0, or 8.0 mg/kg/day, respectively.     

Safety of a novel oxygen-coordinated niacin-bound chromium(III) complex (NBC): I. Two-generation reproduction toxicity study

The objective of this study was to evaluate the effects of a novel oxygen-coordinated niacin-bound chromium(III) complex (NBC) on the reproductive systems of male and female rats, the postnatal maturation and reproductive capacity of their offspring, and possible cumulative effects through multiple generations. Sprague-Dawley rats were maintained on feed containing NBC at dose levels of 0, 4, 15, or 60 ppm for 10 weeks prior to mating, during mating, and, for females through gestation and lactation, across two generations. For the parents (F₀ and F₁) and the offspring (F₁ and F_2a), reproductive parameters such as fertility and mating, gestation, parturition, litters, lactation, sexual maturity and development of offspring were assessed. Results from the current study indicated that dietary exposure of NBC to parental male and female rats of both (F₀ and F₁) the generations during the premating and mating periods, for both sexes, and during gestation and lactation in case of female rats, did not cause any significant incidence of mortality or abnormal clinical signs. Compared to respective controls, NBC exposure did not affect reproductive performance as evaluated by sexual maturity, fertility and mating, gestation, parturition, litter properties, lactation and development of the offspring. Based on the findings of this study, the parental as well as the offspring no-observed-adverse-effect level for NBC was determined to be greater than 60 ppm in diet or equivalent to 7.80 and 8.31 mg/kg body weight/day in male and female rats, respectively.     

Long-term safety evaluation of a novel oxygen-coordinated niacin-bound chromium (III) complex

Chromium (III) is an essential micronutrient required for normal protein, fat and carbohydrate metabolism, as well as helps insulin metabolize fat, turn protein into muscle and convert sugar into energy. A broad spectrum of research investigations including in vitro, in vivo and clinical studies demonstrated the beneficial effects of novel oxygen- coordinated niacin-bound chromium (III) complex (NBC) in promoting glucose-insulin sensitivity, lipid profile, cardioprotective ability and lean body mass. This study examined the long-term safety of NBC by orally administering either 0 or 25 ppm or the human equivalency dose of 1000 microg elemental chromium (III) as NBC per day for 52 consecutive weeks to male and female Sprague-Dawley rats. Animals of each group and each gender were sacrificed on 26, 39, or 52 weeks of treatment. Body weight, physical and ocular health, feed and water intake, selected organ weights as such and as a percentage of liver and brain weight, hepatic lipid peroxidation and DNA fragmentation, hematology and clinical chemistry, and histopathological evaluations were conducted. At 26, 39, or 52 weeks of treatment, body weight gain was significantly reduced by 7.7%, 8.1% and 14.9% in male rats, and 5.5%, 11.4% and 9.6% in female rats, respectively, in the NBC treatment groups. No significant changes were observed in hepatic lipid peroxidation and DNA fragmentation, hematology and clinical chemistry, and histopathological evaluation between control and NBC groups at these time points. These findings, thus far, are in agreement with the subchronic studies in terms of the safety of NBC.     

Synthesis and structural characterization of a novel seven-coordinate cobalt(II) complex: 2,9-Bis(ethanolamine)-1,10-phenanthrolinechlorocobalt(II) chloride

Condensation reaction of 2,9-dicarboxaldehyde-1,10-phenanthroline with 2-aminoethanol followed by NaBH₄ reduction yielded the polydentate Schiff base ligand 2,9-bis(ethanolamine)-1,10-phenanthroline in its reduced form. This ligand was characterized by elemental analysis, LC-MS, IR, UV-Vis and NMR spectroscopy. Reaction of the reduced Schiff base ligand with aqueous solution of cobalt(II) chloride affords 2,9-bis(ethanolamine)-1,10-phenanthrolinechlorocobalt(II) chloride in high yield. Single crystals of the cobalt(II) complex were obtained from the crystallization in ethanol and its structure was elucidated by X-ray structural analysis. The cobalt(II) complex ion was found to be seven-coordinated in a pentagonal bipyramidal geometry, whereby cobalt(II) ion is surrounded by the six donor atoms in the ligand molecule and a chloride ion.     

Five-coordinate cobalt(II) complexes of tris(2-pyridylmethyl)amine (TPA): Synthesis, structural and magnetic characterization of a terephthalato-bridged dinuclear cobalt(II) complex

The cobalt(II) complexes [Co(TPA)Cl]ClO₄ (1), [Co(TPA)Br]ClO₄ (2), [Co(TPA)(H₂O)]Cl(ClO₄) (3) and [Co₂(TPA)₂(μ-tp)](ClO₄)₂ · 2H₂O (4) (TPA = tris(2-methylpyridyl)amine and tp = terephthalate dianion) were synthesized and structurally characterized by UV-vis and IR spectroscopy. The molecular structures of complexes 1 and 4 were determined by X-ray crystallography and their magnetic properties were measured over the temperature range 2-300 K. The coordination geometry around the central Co(II) in these compounds has a distorted trigonal bipyamidal geometry with four nitrogen atoms from the TPA ligand and the fifth coordination site is occupied by Cl⁻ ion in 1, Br⁻ ion in 2, coordinated oxygen atom from H₂O in 3 and by an oxygen atom supplied by the carboxylate group of the bridged terephthalato ligand in 4. The visible spectra of the complexes 1-3 in MeOH show strong distortion toward tetrahedral geometry. For complex 4, analysis of the infrared spectral data for the ν(COO⁻) stretching frequencies of the tp-carboxalato groups reveals the existence of the bis(monodentate) coordination mode for the bridged tp. X-ray data for 1 and 4 show that the former is mononuclear while the latter is dinuclear. The electronic spectrum of 4 in MeOH is in complete agreement with the assigned X-ray geometry around the Co(II) centers. The magnetic behavior of the mononuclear complex 1 is indicative of a high-spin compound with zero-field splitting. The best fit was obtained with ∣D∣ = 7.3 cm⁻¹, g = 2.25. The dinuclear complex 4 exhibits weak antiferromagnetic coupling with a coupling constant J = −0.8 cm⁻¹. The magnetic properties and the structural parameters of 4 are discussed in relation to the other related μ-terephthalato dinuclear Co(II) compounds. The geometry of the coordination sphere around 4 is unique - the CSD compilation listing only one other compound with such a geometry around the dinuclear Co(II) complex and its composition is far different from that in 4. However, they share a common feature of having a weakly antiferromagnetic coupling between Co(II) centers.     

Study of potential binding of biologically important sugars with a dinuclear cobalt(II) complex

The investigation of the sugar–metal ion interactions remains one of the main objectives of carbohydrate coordination chemistry because the interactions between metal ions and carbohydrates are involved in many biochemical processes. The potential binding interaction between a five-coordinate dinuclear cobalt(II) complex, Na₂[Co₂(tcdc)(μ-OAc)] (1) [Na₅tcdc = Sodium-N,N,N′,N′-tetrakis(sodium carboxylate methyl)-2,6-diaminocresolate] and biologically important sugar substrates (d-glucose, d-xylose, and d-mannose) has been studied. In alkaline media, the complex 1 shows an excellent chelating ability toward these sugar substrates. A combined approach of FTIR and UV–vis spectroscopic investigations shows that the complex forms a 1:1 complex/substrate-bound product. UV–vis spectra indicate a significant blue-shift of the absorption maximum of metal complex during carbohydrate coordination highlighting the sugar binding ability of complex 1. The apparent binding constants of the substrate-bound cobalt(II) complexes have been determined from the UV–vis titration experiments.     

Novel cobalt(II) complexes with pyridyl/ether or pyridyl/thioether ligands. The conversion of pyridyl/thioether cobalt(II) complex to pyridyl/sulfinato cobalt(III) compound

Two new cobalt(II) complexes of symmetric hexadentate mixed-ligand N,O [1,12-bis(2-pyridyl)-5,8-dioxa-2,11-diazadodecane (pydado)] and N,S [1,12-bis(2-pyridyl)-5,8-dithia-2,11-diazadodecane (pydadt)] donor atoms have been synthesized as perchlorate salts. The crystal structures show that [Co(pydado)](ClO₄)₂ · H₂O (1) crystallizes in the triclinic space group and [Co(pydadt)](ClO₄)₂ (2) crystallizes in the monoclinic space group P2_1/c. The cation [Co(pydado)]²⁺ is pseudo-octahedral with the two pyridyl groups in trans position. However, in [Co(pydadt)]²⁺ complex, the size of thioether sulfur atoms imposes a distorted octahedral geometry; the pyridyl groups and the sulfur atoms are in trans position. The reaction of the complex 2 and hydrogen peroxide resulted to the oxidation of Co^II into Co^III and the thioether groups of the ligand to sulfinate groups with elimination of the central ethylenic group of pydadt. Thus, complex 2 was converted to bis[3-(2-pyridylmethylamino)ethanesulfinate] cobalt(III) complex (3) {[Co(pynso)₂](ClO₄) · 0.5H₂O}. The X-ray crystal structure reveals that the compound 3 crystallizes in the triclinic space group with the same donor atoms (N_pyridyl, N_amine and S) belonging to the two ligands in cis-position. In aqueous solution, the stability constants of the Co(II) chelates with these two ligands, determined by potentiometry, show the formation of [Co(LH)]³⁺ and [CoL]²⁺ species in all cases. The chelating power of pydadt ligand is slightly greater than that of pydado.     

Insight into citric acid-induced chromium detoxification in rice (Oryza sativa. L)

Abstract

High content of chromium in plants hampers plants’ metabolism, disrupts plant growth and development. Therefore, improving plants’ tolerance to Cr toxicity is very essential. In our present study, we investigated the role of citric acid (CA) on chromium detoxification in terms of stress tolerance in rice. Application of CA under Cr stress restore the growth parameters, total protein content and membrane stability confirming that CA plays important role in Cr detoxification in rice. However, supplementation of CA under Cr stress caused no significant change in root Cr content but increased shoot Cr concentration (97?µg/g) compare with Cr stressed plant (24?µg/gm), suggesting that CA alleviates Cr toxicity by its chelating properties. Moreover, Fe content showed no significant changes due to CA supplementation under Cr stress, implying that Fe regulation is not involved with CA-mediated mitigation of Cr toxicity in rice. Furthermore, increased CAT, POD, and GR activity along with raised metabolites (glutathione and proline) indicates active participation in ROS scavenging and palliate the Cr toxicity in rice.     

Synthesis and characterization of cobalt(II)-salicylate complexes derived from N4-donor ligands: Stabilization of a hexameric water cluster in the lattice host of a cobalt(III)-salicylate complex

The syntheses and structural characterization of four cobalt(II)-salicylate complexes, [(TPA)Co^II(HSA)](ClO₄) (1), [(isoBPMEN)Co^II(HSA)](BPh₄) (2), [(TPzA)Co^II(HSA)](ClO₄) (3) and [(6Me₃TPA)Co^II(HSA)](BPh₄) (4) [TPA = tris(2-pyridylmethyl)amine, isoBPMEN = N¹,N¹-dimethyl-N²,N²-bis(2-pyridylmethyl)ethane-1,2-diamine, TPzA = tris((3,5-dimethyl-1H-pyrazole-1-yl)methyl)amine and 6Me₃TPA = tris(6-methyl-2-pyridylmethyl)amine] are described. While 2, 3 and 4 are unreactive towards dioxygen, 1 reacts slowly with molecular oxygen to a cobalt(III)-salicylate complex, [(TPA)Co^III(SA)](ClO₄) (1a). Two different crystalline forms, 1a and 1a·4H₂O were isolated depending upon the condition of oxidation and crystallization. The solid-state structures of cobalt(III)-salicylate unit in both 1a and 1a·4H₂O show a six-coordinate distorted octahedral coordination geometry at the cobalt(III) center ligated by the tetradentate ligand (TPA) where the dianionic salicylate (SA) binds in a bidentate fashion through one carboxylate and one phenolate oxygen. The hydrated form 1a·4H₂O reveals a hexameric water cluster formation in the inorganic lattice host. The complex cation and the perchlorate counterion are involved in stabilizing the (H₂O)₆ cluster in a rare ‘pentamer planar+1’ conformation. A one-dimensional water tape consisting of edge-shared water hexamers is observed. The water tape represents a subunit of ice structure.     

Synthesis and characterization of two stable paramagnetic octahedral chromium(IV) complexes with dianionic tridentate SNO donor ligands and of a chromium(III) complex with a ONO donor ligand

Two novel paramagnetic octahedral chromium(IV) complexes with dianionic tridentate SNO donor ligands containing extended π-system have been synthesized while only a paramagnetic octahedral chromium(III) complex is obtained when a related dianionic tridentate ONO donor ligand is used under similar conditions. These bischelate complexes [Cr(abtsal)₂] (1) (abtsalH₂ is the Schiff base of o-aminobenzenethiol and salicylaldehyde), [Cr(4-PhTSCsal)₂] · H₂O (2) (4-PhTSCsalH₂ is the Schiff base of 4-phenylthiosemicarbazide and salicylaldehyde) and K[Cr(sap)₂] · H₂O (3) (sapH₂ is the tridentate Schiff base of salicylaldehyde and o-aminophenol) are characterized by elemental analyses, magnetic moment measurements, IR, UV-Vis and EPR spectroscopic studies. Compound 3 has been structurally characterized by X-ray crystallography. Measured room temperature (RT) magnetic moment values are 2.98 BM for 1 and 2.83 BM for 2 indicating a d² system with a triplet ground state in both the cases. On the other hand, the magnetic moment value for 3 is found to be 3.74 BM at RT and is consistent with the presence of three unpaired electrons for a d³ Cr(III) ion. The magnetic moment values rule out the large spin-orbit coupling which is substantiated by the presence of RT EPR signals. Compounds 1 and 2 exhibit very similar powder EPR spectra at RT and LNT, which show the allowed transition ΔM_s = ±1 (g = 2.004 for both 1 and 2) as well as the “forbidden” half-field transition (ΔM_s = ±2) at g = 4.105 for 1 and g = 4.318 for 2, respectively. The X-band LNT frozen glass EPR spectrum of 1 in DMF shows the presence of zero-field split rhombic symmetry character, and results in the parameters g ≅ 2.0, D = 740 G, and E = 260 G. It suggests that the intensity of ΔM_s = ±2 forbidden transition is large due to the large D value. The X-band frozen glass EPR spectrum of compound 3 in DMF is found to be very similar to that reported for trans-[Cr(py)₄F₂]⁺ in DMF-H₂O-MeOH glass. The large difference (∼700 mV) in the reduction potential for the two octahedral complexes 1 (−1.40 V) and 3 (−0.70 V) is attributed to the difference in their metal ion oxidation states.     

Analysis of EDTA-chelatable proteins from DNA-protein crosslinks induced by a carcinogenic chromium(VI) in cultured intact human cells

DNA-protein crosslinks (DPCs) were induced in intact human leukemic T-lymphocyte MOLT4 cells or isolated nuclei by treatment with potassium chromate, chromium(III) chloride hexahydrate or x-rays. The proteins complexed to DNA were analyzed by two-dimensional SDS-polyacrylamide gel electrophoresis (PAGE). A group of identical non-histone proteins was crosslinked to DNA by any of the three treatments, except that a 51 kDa basic protein was additionally complexed to DNA when either potassium chromate or chromium(III) chloride hexahydrate was the crosslinking agent. Treatment of chromate-induced DNA-protein crosslinks with EDTA or thiourea followed by ultracentifugation dissociated the major proteins from the complex indicating that these proteins were crosslinked to DNA by direct participation of a EDTA-chelatable form of chromium such as Cr(III) through sulfur containing amino acid residues. The 51 kDa protein was not seen in the post-EDTA pellet but was present in the post-thiourea pellet, indicating that it was also crosslinked to DNA by Cr(III) through non-sulfur-containing amino acids. Digestion of x-rays-induced DPCs by DNase I also revealed this protein on two-dimensional gels indicating that the same protein was also crosslinked by oxidative mechanisms. The involvement of oxidative mechanisms in the crosslinking process was indicated as the majority of the proteins in chromate-induced DPCs were resistant to EDTA and thiourea treatment, and were found to crosslink to DNA when x-rays were used as the crosslinking agent. These results suggest that the chromate-induced DPCs are formed by the generation of reactive oxygen species during the intracellular chromate reduction as well as by the biologically generated Cr(III). About 19% of DNA-protein crosslinks actually involve Cr(III) crosslinking DNA to proteins, about 14% involve Cr(III) crosslinking DNA to proteins through non-sulfhydryl containing moieties and about 5% involve Cr(III) crosslinking DNA to sulfhydryl groups on proteins. The remaining 81% of DNA-protein crosslinks appear to be oxidatively crosslinked out of which about 45% appear to be through sulfhydryl groups and another 36% appear to be through non-sulfhydryl groups.     

Electrochemical and spectroscopic characterization of new cobalt(II) complexes. Catalytic activity in oxidation reactions by molecular oxygen

The synthesis and characterization of some new complexes with tetradentate Schiff bases derived from bis(salicylaldehyde)etylenediimine, H₂Salen are reported in this paper. The Co(II) Schiff bases complexes investigated are: (bis(5-nitro-salicylaldehyde) ethylenediiminato)cobalt(II), (CoNSalen); (bis(-ethyl-salicylaldehyde) ethylenediiminato)cobalt(II) (CoEtSalen); (bis(-ethyl-3,5-diiode-salicylaldehyde) ethylenediiminato) cobalt(II),(CoDIEtSalen); (bis(,5-dimethyl-3-iode-salicylaldehyde)ethylenediiminato)cobalt(II) (CoDMISalen) and (bis(salicylaldehyde)methylene-p,p′-diphenylene)cobalt(II), (CoSalmbfn). The characterization of the complexes was performed by elemental analysis, UV–Vis, FTIR spectroscopy, powder X-ray diffraction and cyclic voltammetry. Pyridine (py), present in the solution of complexes in DMF, coordinates to the metal ion in axial position, inducing a significant decrease of the redox potentials. Significant influences have the substituents grafted on ligands’ molecules. The separated complexes evince catalytic activity in the oxidation reaction of 2,6-di-t-butylphenol with molecular oxygen. These complexes seem capable of forming reversible adducts with molecular oxygen.     

Facile and stereoselective condensation of acetone with ammonia ligands on cobalt(III): structure of a N-bonded cyanate complex containing the 2-methyl-2-amino-4-imino-pentane ligand

The complex [(NH₃)₅CoO₃SCF₃](CF₃SO₃)₂ reacts with excess NaNCO in warm acetone solution to give, stereoselectively, a Schiff base complex (40%) which has been characterized by standard NMR techniques as one of the six isomers of [Co{NH₂C(CH₃)₂CH₂C(CH₃)=NH}₂(NH₃)NCO](ClO₄)₂ · H₂O, confirmed by a single crystal X-ray structural analysis. Schiff base formation in non-basic conditions for kinetically inert Co(III) complexes is unprecedented. Also, this is only the second cyanate complex of pentaaminecobalt(III) to be structurally characterized (CoNCO: Co–N, 1.908 Å; N–C, 1.152 Å; C–O, 1.206 Å; Co–N–C, 170°; N–C–O, 177°).     

Reactivity of a cobalt(III)-peroxo complex in oxidative nucleophilic reactions

A mononuclear cobalt(III)-peroxo complex bearing a macrocyclic tetradentate N₄ ligand, [Co^III(TMC)(O₂)]⁺ (TMC = 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane), was generated in the reaction of [Co^II(TMC)]²⁺ and H₂O₂ in the presence of triethylamine in CH₃CN. The reactivity of the cobalt(III)-peroxo complex was investigated in aldehyde deformylation with various aldehydes and compared with that of iron(III)- and manganese(III)-peroxo complexes, such as [Fe^III(TMC)(O₂)]⁺ and [Mn^III(TMC)(O₂)]⁺. In this reactivity comparison, the reactivities of metal-peroxo species were found to be in the order of [Mn^III(TMC)(O₂)]⁺ > [Co^III(TMC)(O₂)]⁺ > [Fe^III(TMC)(O₂)]⁺. A positive Hammett ρ value of 1.8, obtained in the reactions of [Co^III(TMC)(O₂)]⁺ and para-substituted benzaldehydes, demonstrates that the aldehyde deformylation by the cobalt(III)-peroxo species occurs via a nucleophilic reaction.     

Biomonitoring of chromium(VI) deposited in pulmonary tissues: Pilot studies of a magnetic resonance imaging technique in a post-mortem rodent model

The biomonitoring of individuals exposed to chromium(VI) by inhalation is often based on determinations of chromium in body fluids such as blood, plasma or urine, or on assessments of DNA damage in non-lung surrogate tissues such as peripheral blood lymphocytes. These techniques are of some use as biomarkers of internal exposure or biological effect, mainly in the case of soluble chromium(VI) compounds, but they provide at best only indirect information about chromium(VI) concentrations in the main target organ of interest – the lung. An urgent need exists for a non-invasive technique to permit the visualization and quantification of chromium(VI) in the lung of exposed humans. This study details the development of a lung imaging technique based on the detection of paramagnetic chromium using magnetic resonance imaging (MRI). The intracellular reductive conversion of chromium(VI) is a crucial bioactivation step in its carcinogenicity, and the MRI method described here relies on the conversion of non-paramagnetic (MRI ‘silent’) chromium(VI) to detectable paramagnetic species such as chromium(III). Initial studies with chromium(III) revealed that a range of 2.5–5 μg chromium(III) instilled in rat lung is considered to be the lower limit of detection of this method. It was possible to demonstrate the presence of 30 μg chromium(VI) in our post-mortem rat model. The ultimate objective of this work is to determine whether this technique has applicability to the biomonitoring of chromium(VI) inhalation exposures that result in internalized lung doses in human subjects.     

Biomonitoring of chromium(VI) deposited in pulmonary tissues: Pilot studies of a magnetic resonance imaging technique in a post-mortem rodent model

The biomonitoring of individuals exposed to chromium(VI) by inhalation is often based on determinations of chromium in body fluids such as blood, plasma or urine, or on assessments of DNA damage in non-lung surrogate tissues such as peripheral blood lymphocytes. These techniques are of some use as biomarkers of internal exposure or biological effect, mainly in the case of soluble chromium(VI) compounds, but they provide at best only indirect information about chromium(VI) concentrations in the main target organ of interest - the lung. An urgent need exists for a non-invasive technique to permit the visualization and quantification of chromium(VI) in the lung of exposed humans. This study details the development of a lung imaging technique based on the detection of paramagnetic chromium using magnetic resonance imaging (MRI). The intracellular reductive conversion of chromium(VI) is a crucial bioactivation step in its carcinogenicity, and the MRI method described here relies on the conversion of non-paramagnetic (MRI 'silent') chromium(VI) to detectable paramagnetic species such as chromium(III). Initial studies with chromium(III) revealed that a range of 2.5-5 μg chromium(III) instilled in rat lung is considered to be the lower limit of detection of this method. It was possible to demonstrate the presence of 30 μg chromium(VI) in our post-mortem rat model. The ultimate objective of this work is to determine whether this technique has applicability to the biomonitoring of chromium(VI) inhalation exposures that result in internalized lung doses in human subjects.